KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Other Operating Expenses (2016 - 2026)

Zimmer Biomet Holdings has reported Other Operating Expenses over the past 18 years, most recently at $760.2 million for Q1 2026.

  • For Q1 2026, Other Operating Expenses rose 1.71% year-over-year to $760.2 million; the TTM value through Mar 2026 reached $3.4 billion, up 14.58%, while the annual FY2025 figure was $3.4 billion, 12.96% up from the prior year.
  • Other Operating Expenses for Q1 2026 was $760.2 million at Zimmer Biomet Holdings, down from $1.1 billion in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $1.1 billion in Q4 2025 and troughed at $667.9 million in Q3 2022.
  • A 5-year average of $770.5 million and a median of $744.3 million in 2024 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: dropped 26.32% in 2023 and later skyrocketed 41.01% in 2025.
  • Year by year, Other Operating Expenses stood at $1.0 billion in 2022, then dropped by 26.32% to $750.3 million in 2023, then increased by 3.81% to $778.9 million in 2024, then skyrocketed by 41.01% to $1.1 billion in 2025, then tumbled by 30.78% to $760.2 million in 2026.
  • Business Quant data shows Other Operating Expenses for ZBH at $760.2 million in Q1 2026, $1.1 billion in Q4 2025, and $722.8 million in Q3 2025.